Cargando…
Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing
Omicron has become the dominant SARS-CoV-2 variant globally since December 2021, with distinct waves being associated with separate Omicron sublineages. Rapid detection of BA.1, BA.2, BA.4, and BA.5 was accomplished in the province of Alberta, Canada, through the design and implementation of real-ti...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576821/ https://www.ncbi.nlm.nih.gov/pubmed/37838804 http://dx.doi.org/10.1038/s41598-023-44796-y |
_version_ | 1785121199252045824 |
---|---|
author | Zelyas, Nathan Pabbaraju, Kanti Croxen, Matthew A. Lynch, Tarah McCullough, Emily Murphy, Stephanie A. Shokoples, Sandy Wong, Anita Kanji, Jamil N. Tipples, Graham |
author_facet | Zelyas, Nathan Pabbaraju, Kanti Croxen, Matthew A. Lynch, Tarah McCullough, Emily Murphy, Stephanie A. Shokoples, Sandy Wong, Anita Kanji, Jamil N. Tipples, Graham |
author_sort | Zelyas, Nathan |
collection | PubMed |
description | Omicron has become the dominant SARS-CoV-2 variant globally since December 2021, with distinct waves being associated with separate Omicron sublineages. Rapid detection of BA.1, BA.2, BA.4, and BA.5 was accomplished in the province of Alberta, Canada, through the design and implementation of real-time reverse transcriptase PCR assays targeting S:N501Y, S:ins214EPE, S:H69/V70, ORF7b:L11F, and M:D3N. Using the combination of results for each of these markers, samples could be designated as belonging to sublineages within BA.1, BA.2, BA.4, or BA.5. The analytical sensitivity of these markers ranged from 132 to 2229 copies/mL and in-laboratory accuracy was 98.9–100%. A 97.3% agreement using 12,592 specimens was demonstrated for the assays compared to genome sequencing. The use of these assays, combined with genome sequencing, facilitated the surveillance of SARS-CoV-2 lineages throughout a BA.5-dominated period. |
format | Online Article Text |
id | pubmed-10576821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105768212023-10-16 Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing Zelyas, Nathan Pabbaraju, Kanti Croxen, Matthew A. Lynch, Tarah McCullough, Emily Murphy, Stephanie A. Shokoples, Sandy Wong, Anita Kanji, Jamil N. Tipples, Graham Sci Rep Article Omicron has become the dominant SARS-CoV-2 variant globally since December 2021, with distinct waves being associated with separate Omicron sublineages. Rapid detection of BA.1, BA.2, BA.4, and BA.5 was accomplished in the province of Alberta, Canada, through the design and implementation of real-time reverse transcriptase PCR assays targeting S:N501Y, S:ins214EPE, S:H69/V70, ORF7b:L11F, and M:D3N. Using the combination of results for each of these markers, samples could be designated as belonging to sublineages within BA.1, BA.2, BA.4, or BA.5. The analytical sensitivity of these markers ranged from 132 to 2229 copies/mL and in-laboratory accuracy was 98.9–100%. A 97.3% agreement using 12,592 specimens was demonstrated for the assays compared to genome sequencing. The use of these assays, combined with genome sequencing, facilitated the surveillance of SARS-CoV-2 lineages throughout a BA.5-dominated period. Nature Publishing Group UK 2023-10-14 /pmc/articles/PMC10576821/ /pubmed/37838804 http://dx.doi.org/10.1038/s41598-023-44796-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zelyas, Nathan Pabbaraju, Kanti Croxen, Matthew A. Lynch, Tarah McCullough, Emily Murphy, Stephanie A. Shokoples, Sandy Wong, Anita Kanji, Jamil N. Tipples, Graham Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing |
title | Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing |
title_full | Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing |
title_fullStr | Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing |
title_full_unstemmed | Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing |
title_short | Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing |
title_sort | tracking sars-cov-2 omicron lineages using real-time reverse transcriptase pcr assays and prospective comparison with genome sequencing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576821/ https://www.ncbi.nlm.nih.gov/pubmed/37838804 http://dx.doi.org/10.1038/s41598-023-44796-y |
work_keys_str_mv | AT zelyasnathan trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT pabbarajukanti trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT croxenmatthewa trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT lynchtarah trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT mcculloughemily trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT murphystephaniea trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT shokoplessandy trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT wonganita trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT kanjijamiln trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing AT tipplesgraham trackingsarscov2omicronlineagesusingrealtimereversetranscriptasepcrassaysandprospectivecomparisonwithgenomesequencing |